FABP1 and metabolic dysfunction-associated steatotic liver disease: It has been reported that the FABP1 liver level represents a diagnostic marker in NAFLD [44], and circulating FABP1 have been found to be higher in type 2 diabetes mellitus patients with NAFLD [45].